These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29880282)

  • 61. Coordination-Induced Assembly of Intelligent Polysaccharide-Based Phototherapeutic Nanoparticles for Cancer Treatment.
    Tian Y; Guo R; Wang Y; Yang W
    Adv Healthc Mater; 2016 Dec; 5(24):3099-3104. PubMed ID: 27860415
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lipid-based drug delivery systems for cancer treatment.
    Arias JL; Clares B; Morales ME; Gallardo V; Ruiz MA
    Curr Drug Targets; 2011 Jul; 12(8):1151-65. PubMed ID: 21443475
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Theranostic Liposome-Nanoparticle Hybrids for Drug Delivery and Bioimaging.
    Seleci M; Ag Seleci D; Scheper T; Stahl F
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28671589
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bioengineered bacterial outer membrane vesicles: what is their potential in cancer therapy?
    Gujrati VB; Jon S
    Nanomedicine (Lond); 2014 May; 9(7):933-5. PubMed ID: 24978458
    [No Abstract]   [Full Text] [Related]  

  • 65. Hyperthermia-mediated drug delivery induces biological effects at the tumor and molecular levels that improve cisplatin efficacy in triple negative breast cancer.
    Dunne M; Dou YN; Drake DM; Spence T; Gontijo SML; Wells PG; Allen C
    J Control Release; 2018 Jul; 282():35-45. PubMed ID: 29673642
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Construction and evaluation of pH-sensitive immunoliposomes for enhanced delivery of anticancer drug to ErbB2 over-expressing breast cancer cells.
    Li T; Amari T; Semba K; Yamamoto T; Takeoka S
    Nanomedicine; 2017 Apr; 13(3):1219-1227. PubMed ID: 27965166
    [TBL] [Abstract][Full Text] [Related]  

  • 67. An imaging-guided platform for synergistic photodynamic/photothermal/chemo-therapy with pH/temperature-responsive drug release.
    Lv R; Yang P; He F; Gai S; Yang G; Dai Y; Hou Z; Lin J
    Biomaterials; 2015 Sep; 63():115-27. PubMed ID: 26093792
    [TBL] [Abstract][Full Text] [Related]  

  • 68. NGR-modified pH-sensitive liposomes for controlled release and tumor target delivery of docetaxel.
    Gu Z; Chang M; Fan Y; Shi Y; Lin G
    Colloids Surf B Biointerfaces; 2017 Dec; 160():395-405. PubMed ID: 28965079
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Nanomedicine for cancer diagnosis and therapy: advancement, success and structure-activity relationship.
    Bhise K; Sau S; Alsaab H; Kashaw SK; Tekade RK; Iyer AK
    Ther Deliv; 2017 Nov; 8(11):1003-1018. PubMed ID: 29061101
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cargo-Free Nanomedicine with pH Sensitivity for Codelivery of DOX Conjugated Prodrug with SN38 To Synergistically Eradicate Breast Cancer Stem Cells.
    Sun N; Zhao C; Cheng R; Liu Z; Li X; Lu A; Tian Z; Yang Z
    Mol Pharm; 2018 Aug; 15(8):3343-3355. PubMed ID: 29923726
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Engineering graphene oxide with ultrasmall SPIONs and smart drug release for cancer theranostics.
    Luo Y; Tang Y; Liu T; Chen Q; Zhou X; Wang N; Ma M; Cheng Y; Chen H
    Chem Commun (Camb); 2019 Feb; 55(13):1963-1966. PubMed ID: 30681672
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hybrid liposomes showing enhanced accumulation in tumors as theranostic agents in the orthotopic graft model mouse of colorectal cancer.
    Okumura M; Ichihara H; Matsumoto Y
    Drug Deliv; 2018 Nov; 25(1):1192-1199. PubMed ID: 29790374
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Environmental pH-sensitive polymeric micelles for cancer diagnosis and targeted therapy.
    Gao GH; Li Y; Lee DS
    J Control Release; 2013 Aug; 169(3):180-4. PubMed ID: 23195533
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Nanomedicine-based combination anticancer therapy between nucleic acids and small-molecular drugs.
    Huang W; Chen L; Kang L; Jin M; Sun P; Xin X; Gao Z; Bae YH
    Adv Drug Deliv Rev; 2017 Jun; 115():82-97. PubMed ID: 28624478
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lipid prodrug nanocarriers in cancer therapy.
    Mura S; Bui DT; Couvreur P; Nicolas J
    J Control Release; 2015 Jun; 208():25-41. PubMed ID: 25617724
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synthesis and characterization of acetyl curcumin-loaded core/shell liposome nanoparticles via an electrospray process for drug delivery, and theranostic applications.
    Reddy AS; Lakshmi BA; Kim S; Kim J
    Eur J Pharm Biopharm; 2019 Sep; 142():518-530. PubMed ID: 31365879
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Enzyme-Responsive Liposomes for the Delivery of Anticancer Drugs.
    Fouladi F; Steffen KJ; Mallik S
    Bioconjug Chem; 2017 Apr; 28(4):857-868. PubMed ID: 28201868
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Multifunctional Porous Iron Oxide Nanoagents for MRI and Photothermal/Chemo Synergistic Therapy.
    Hu Y; Hu H; Yan J; Zhang C; Li Y; Wang M; Tan W; Liu J; Pan Y
    Bioconjug Chem; 2018 Apr; 29(4):1283-1290. PubMed ID: 29402074
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Selenium-functionalized liposomes for systemic delivery of doxorubicin with enhanced pharmacokinetics and anticancer effect.
    Xie Q; Deng W; Yuan X; Wang H; Ma Z; Wu B; Zhang X
    Eur J Pharm Biopharm; 2018 Jan; 122():87-95. PubMed ID: 29032193
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Theranostics with Hybrid Liposomes in an Orthotopic Graft Model Mice of Breast Cancer.
    Ichihara H; Okumura M; Tsujimura K; Matsumoto Y
    Anticancer Res; 2018 Oct; 38(10):5645-5654. PubMed ID: 30275183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.